CPAP remains the gold standard for treating obstructive sleep apnea — but in clinical reality, a substantial share of patients can't tolerate it long-term. For people with a genuine, documented CPAP intolerance, three real, evidence-backed alternatives exist: oral appliances, positional therapy, and the implantable Inspire hypoglossal nerve stimulator — each with specific qualification criteria and limitations, not a universal substitute.
CPAP remains the gold standard — but it doesn't work in practice for everyone
Continuous positive airway pressure (CPAP) therapy is the first-line treatment for moderate and severe obstructive sleep apnea (OSA) — it pneumatically "splints" the airway open, preventing it from collapsing, and in studies is linked to reduced blood pressure and better cardiovascular control in patients who use it consistently. This article isn't an invitation to avoid CPAP — it's a guide to real, evidence-based options for people who, despite proper mask and pressure fitting and support from a sleep specialist, remain unable to tolerate CPAP long-term.
This isn't a list of ways to skip trying CPAP
All the alternatives described here are meant for patients with a sleep-study-documented sleep apnea diagnosis who have genuinely attempted CPAP therapy and can't tolerate it long-term — not for people who want to bypass CPAP as a first step. CPAP remains the therapy with the strongest evidence and broadest effectiveness, especially in severe OSA.
Why people stop using CPAP
CPAP intolerance is a well-recognized, common problem in sleep medicine — long-term adherence estimates (regular, nightly use) vary across studies, but a substantial share of patients reduce or stop therapy within the first year. The most common barriers are a feeling of claustrophobia from a mask covering the nose or nose and mouth, dryness of the nasal and throat mucosa, mask leaks causing noise and air loss, skin irritation where the mask contacts the face, the discomfort of sleeping with a device and hose all night, and difficulty traveling and using the device away from home.
Some of these barriers can be effectively addressed by changing mask type, adding a humidifier, desensitization (gradually getting used to wearing the mask while awake before bed), or consulting a sleep technician for better pressure fitting. However, in some patients, even after exhausting these options, CPAP intolerance remains a real, persistent clinical problem — and it's for this group that the alternatives below exist.
Oral appliances — mechanism and evidence
Oral appliances, also called mandibular advancement devices (MADs), are custom-fitted devices made by a dentist or sleep specialist, worn in the mouth during sleep, that advance the lower jaw (and the tongue attached to it) forward, widening the throat space and reducing the risk of its collapse. This is the best-studied and most widely available CPAP alternative, with real, though smaller than CPAP's, effectiveness.
Mandibular advancement devices vs nasal-continuous positive airway pressure in the treatment of obstructive sleep apnoea. Systematic review and meta-analysis
A systematic review and meta-analysis comparing oral appliances with CPAP for treating obstructive sleep apnea ranging from mild to severe. CPAP was significantly more effective at reducing the AHI and improving post-treatment lowest blood oxygen saturation. However, no significant difference was found between the two methods in reducing the Epworth Sleepiness Scale (ESS) — subjective daytime sleepiness — meaning that despite a weaker objective effect (AHI), oral appliances may provide comparable relief from everyday symptoms for some patients.
Continuous Positive Airway Pressure vs Mandibular Advancement Devices in the Treatment of Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis
Moderate evidence
Pattipati M, Gudavalli G, Zin M, Dhulipalla L, Kolack E, Karki M, Devarakonda PK, Yoe L · Cureus · 2022
An updated meta-analysis of eight randomized and crossover trials comparing CPAP with oral appliances. Both methods significantly reduced AHI and improved lowest oxygen saturation relative to baseline, with CPAP remaining more effective on these objective measures. No significant difference was found in Epworth Sleepiness Scale scores between the two methods before and after treatment, confirming earlier findings — for some patients, subjective symptom relief may be comparable even when the objective reduction in apnea events is smaller than with CPAP.
An important practical distinction: oral appliances are relatively well studied and effective in mild-to-moderate OSA, while in severe sleep apnea their effectiveness is far less convincing, and reviews found no trials comparing the two methods exclusively in a mild-OSA population — a real limitation of the evidence base itself. In clinical practice, oral appliances are often recommended as a reasonable option for patients who cannot or will not continue CPAP, especially with mild-to-moderate severity.
Positional therapy — who it genuinely makes sense for
In some patients, apnea events worsen noticeably when lying on the back (so-called positional OSA, or POSA) — gravity makes it easier for the tongue and throat tissues to collapse in this position than on the side. Positional therapy, once achieved with homemade methods like a tennis ball sewn into pajamas, now takes the form of small devices (sleep position trainers, SPT) worn on the chest or neck that gently vibrate when they detect a supine position, prompting a position change without fully waking the person.
A randomized, controlled trial of positional therapy versus oral appliance therapy for position-dependent sleep apnea
Moderate evidence
de Vries GE, Hoekema A, Doff MHJ, Kerstjens HAM, Meijer PM, van der Hoeven JH, Wijkstra PJ · Sleep Medicine · 2017
A multicenter randomized trial of 99 patients with mild-to-moderate position-dependent sleep apnea (AHI 5-30/h), comparing positional therapy (SPT) with an oral appliance. After 3 months, median AHI fell from 13.0 to 7.0 in the positional therapy group and from 11.7 to 9.1 in the oral appliance group (both reductions statistically significant, p<0.001). Adherence (using the device at least 4 hours/night, at least 5 nights/week) did not differ significantly between groups, though it was numerically higher for positional therapy (89.3% vs 81.3%). The authors judged both methods comparably effective in this specific, pre-selected population of patients with clearly position-dependent apnea.
A key limitation of positional therapy: it works well only in patients whose apnea is genuinely and substantially positional — meaning AHI is significantly higher supine than in other positions, which should be confirmed on a sleep study, not guessed. In patients whose apnea is similarly severe regardless of position, positional therapy doesn't address the main mechanism of the problem and shouldn't be treated as a standalone alternative.
Personalized for you
Struggling with sleep?
Answer a few questions about your sleep, stress, diet, and lifestyle. VitMode will show you which areas might need the most attention and which supplements could be worth considering.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Inspire is an FDA-approved, surgically implanted hypoglossal nerve stimulation system — the most invasive option described here, reserved for a tightly defined group of patients with moderate-to-severe OSA who cannot tolerate or don't benefit from CPAP. The device, implanted under the skin near the neck and chest, detects the patient's breathing cycle and, during inhalation, stimulates the hypoglossal nerve, causing the tongue to move forward and keep the throat open — mechanically replacing what proper muscle tone provides in a healthy person.
Upper-Airway Stimulation for Obstructive Sleep Apnea (STAR trial)
Strong evidence
Strollo PJ Jr, Soose RJ, Maurer JT, et al. · The New England Journal of Medicine · 2014
The pivotal STAR trial (Stimulation Therapy for Apnea Reduction) that led to FDA clearance of the Inspire device. In 126 CPAP-intolerant patients, median AHI fell from 29.3 to 9.0 events per hour after 12 months of stimulation, with serious adverse events in about 2% of participants. Trial participants met strict criteria: AHI between 20 and 50 events per hour, BMI ≤32 kg/m², fewer than 25% central or mixed events, and no complete concentric collapse of the soft palate on drug-induced sleep endoscopy (DISE). A 42-month follow-up confirmed sustained efficacy and safety with no loss of therapeutic effect over time.
Real Inspire qualification criteria (not just "it's an option")
Moderate-to-severe obstructive sleep apnea confirmed on a sleep study, with documented intolerance or failure of CPAP despite a genuine attempt at therapy
AHI within the range used in the pivotal STAR trial (20-50/h), though current FDA guidance allows a broader range (up to roughly 65-100/h depending on indication) — evidence outside the original STAR range is weaker
BMI typically ≤32-40 kg/m² depending on specific center and payer criteria — higher body weight means more soft tissue collapsing in the throat, which limits the effectiveness of tongue stimulation alone
Fewer than 25% central or mixed events in total AHI — Inspire addresses mechanical obstruction, not the respiratory-control instability characteristic of central apnea
No complete concentric collapse of the soft palate on a DISE exam performed before qualification — this collapse pattern doesn't respond to tongue stimulation and is a formal contraindication
Acceptance of the surgical procedure to implant the device and regular follow-up visits to adjust stimulation parameters
Myth versus reality
Myth
If I can't stand sleeping with a mask, I can just switch straight to an oral appliance or ask for Inspire, skipping CPAP.
Fact
All three alternatives described here make clinical and scientific sense only as options for patients with a documented, genuine attempt at and intolerance of CPAP — not as a way to avoid that attempt. Inspire in particular requires formally demonstrated CPAP intolerance or failure as a qualification condition, not just a subjective dislike of it.
Another common misconception is treating oral appliances as a "weaker but safer" version of CPAP with no downsides — in practice, long-term wear of an oral appliance can cause changes in bite and tooth position, and in some patients jaw-joint discomfort, which requires regular dental monitoring, not just a one-time fitting.
Limitations and risks of each option
None of these methods is without drawbacks
Oral appliances are mainly effective in mild-to-moderate OSA and require regular dental checkups because of the risk of bite changes with long-term use. Positional therapy only works in patients whose apnea is genuinely positional, which must be confirmed on a sleep study — in everyone else, it doesn't address the main mechanism of the problem. Inspire requires surgery with the usual surgical risks (anesthesia, infection, nerve damage), is expensive and available at a limited number of centers, and its evidence is strongest in the population meeting the original STAR trial's strict criteria — outside that range, effectiveness is less well established.
Method
Who it's for
Evidence level
Oral appliance (MAD)
Mild-to-moderate OSA, CPAP intolerance
Moderate — CPAP more effective objectively, similar effect on sleepiness
Positional therapy (SPT)
Clearly positional apnea (worsens supine)
Moderate — comparable to oral appliance in this group
Inspire (hypoglossal nerve stimulation)
Moderate-severe OSA, documented CPAP intolerance, meets DISE/BMI/AHI criteria
Strong within STAR trial criteria
CPAP alternatives at a glance
Our editorial recommendation
CPAP remains the first-line therapy with the broadest range of effectiveness in obstructive sleep apnea, and none of the alternatives described here change that hierarchy. What this article changes is the reminder that genuine, documented CPAP intolerance isn't a dead end — real, evidence-based options exist, each with a specific patient group it makes the most sense for, and specific limitations worth knowing before deciding.
The choice between an oral appliance, positional therapy, and Inspire shouldn't come from marketing or convenience, but from specific sleep-study results (apnea severity, position dependence, airway collapse pattern on DISE) and a conversation with a sleep medicine specialist who can judge which option genuinely fits a given patient's profile.
CPAP intolerance is a real clinical problem, not something to be ashamed of or a reason to give up on treatment. But "CPAP alternative" doesn't mean "any option for anyone" — each one has its own specific indications, and those, not a desire to avoid the mask, should drive the choice.
Dr. Piotr Zieliński, VitMode editorial team
Frequently asked questions
Guidelines and evidence treat oral appliances as an option for patients with documented CPAP intolerance or failure, not as an equally valid first-line choice — CPAP remains more effective objectively, especially in moderate and severe OSA. Any decision to switch therapies is best made together with a sleep medicine physician.
This requires a sleep study (polysomnography or a home sleep apnea test) with body position tracking, which shows whether AHI is significantly higher lying on your back than in other positions. Without that confirmation, positional therapy may not address the actual cause of the problem for a given patient.
Based on STAR trial criteria and current clinical practice: patients with moderate-to-severe OSA, documented CPAP intolerance or failure, BMI within the approved range (typically up to 32-40 kg/m² depending on the center), fewer than 25% central/mixed events, and no complete concentric collapse of the soft palate confirmed on a DISE exam.
Long-term wear of an oral appliance can gradually shift tooth position and bite, and in some patients cause jaw-joint discomfort, which is why this therapy requires regular dental monitoring, not just a one-time fitting.
It's a surgical procedure to implant a pulse generator and electrodes near the neck and chest, usually done outpatient or with a short hospital stay. Like any surgery, it carries the usual risks of anesthesia, infection, or, rarely, nerve damage, which should be discussed with the surgeon beforehand.
No — it works well only in patients whose apnea is clearly positional, meaning significantly worse lying on the back than in other positions. In patients whose apnea doesn't depend on sleep position, positional therapy doesn't address the main mechanism of the problem and shouldn't be the only method used.
Yes, in some cases — for example, positional therapy has been combined with an oral appliance in patients with residual positional apnea despite using the appliance, which produced an additional AHI reduction in small studies. Decisions about combining therapies should always go through a sleep medicine physician based on a follow-up sleep study.
Specialist physician in endocrinology, scientific consultant
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
